Sinovac Biotech Ltd. received the Good Manufacturing Practice (GMP) certification for its recently opened filling and packaging production facility. The GMP certification provides for an overall annual production capacity of 20 million doses, with the capability to produce up to 40 million doses. This level of production allows for increased sales of Sinovac’s marketed vaccines,  More details...

Stock Symbol: (NYSE Alternext US: SVA)